Published in Br J Cancer on January 25, 2011
Defining the role of mTOR in cancer. Cancer Cell (2007) 21.63
Control of EGF receptor signaling by clathrin-mediated endocytosis. Science (1996) 6.01
Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer (2007) 5.71
miR-21: a small multi-faceted RNA. J Cell Mol Med (2009) 5.59
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer (2009) 2.76
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res (2004) 2.43
MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun (2009) 2.39
Protein kinase C and the regulation of the actin cytoskeleton. Cell Signal (2005) 2.35
Targeting the protein kinase C family: are we there yet? Nat Rev Cancer (2007) 2.29
Phospholipase D in cell proliferation and cancer. Mol Cancer Res (2003) 2.13
Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res (2005) 2.11
Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun (2002) 2.09
Regulation of mTOR by phosphatidic acid? Cancer Res (2007) 2.05
The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1beta (Rsk-2) and p70 S6 kinase. FEBS Lett (1997) 2.03
Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. Biochim Biophys Acta (2009) 1.89
Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res (2001) 1.82
Regulation of CTP:phosphocholine cytidylyltransferase by amphitropism and relocalization. Trends Biochem Sci (2000) 1.76
Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int J Cancer (2007) 1.72
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res (2010) 1.65
Choline transport for phospholipid synthesis. Exp Biol Med (Maywood) (2006) 1.56
Protein kinase C (PKC) family in cancer progression. Cancer Lett (2006) 1.54
Measurement of phospholipase D activity. Anal Biochem (1997) 1.53
Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate (2002) 1.52
Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism. Carcinogenesis (2008) 1.48
Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res (2002) 1.40
Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. Mol Pharm (2006) 1.37
The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci (2003) 1.32
Uncoupling of membrane ruffling and pinocytosis during Ras signal transduction. J Biol Chem (1997) 1.29
Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling. Oncogene (2009) 1.28
Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors. Oncogene (1993) 1.27
Signalling roles of mammalian phospholipase D1 and D2. Cell Mol Life Sci (2001) 1.24
Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment. PLoS One (2009) 1.23
Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reaction. Biochem Biophys Res Commun (1989) 1.21
Exploitation of protein kinase C: a useful target for cancer therapy. Cancer Treat Rev (2008) 1.21
Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. Am J Pathol (1999) 1.20
Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells. Biochem Biophys Res Commun (2003) 1.20
Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells. Cancer Res (2008) 1.19
Phorbol esters stimulate the rapid release of choline from prelabelled cells. Carcinogenesis (1981) 1.19
Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system? Br J Cancer (2005) 1.17
Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ (1996) 1.17
Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol (1991) 1.16
Elevated phosphocholine concentration in ras-transformed NIH 3T3 cells arises from increased choline kinase activity, not from phosphatidylcholine breakdown. Mol Cell Biol (1989) 1.14
Conventional PKC-alpha, novel PKC-epsilon and PKC-theta, but not atypical PKC-lambda are MARCKS kinases in intact NIH 3T3 fibroblasts. J Biol Chem (1997) 1.14
Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells. Mol Cancer (2009) 1.13
Functional expression of sv40 in normal human prostatic epithelial and fibroblastic cells - differentiation pattern of nontumorigenic cell-lines. Int J Oncol (1995) 1.12
The MARCKS family of phospholipid binding proteins: regulation of phospholipase D and other cellular components. Biochem Cell Biol (2004) 1.12
Phospholipid metabolism in bradykinin-stimulated human fibroblasts. II. Phosphatidylcholine breakdown by phospholipases C and D; involvement of protein kinase C. J Biol Chem (1991) 1.09
Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate. Oncol Rep (2004) 1.09
Involvement of phosphatidylcholine-specific phospholipase C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts. J Biol Chem (1997) 1.07
Generation of phosphorylcholine as an essential event in the activation of Raf-1 and MAP-kinases in growth factors-induced mitogenic stimulation. J Cell Biochem (1995) 1.07
Identification of multiple PKC isoforms in Swiss 3T3 cells: differential down-regulation by phorbol ester. J Cell Physiol (1992) 1.05
Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells. J Biochem Mol Biol (2005) 1.05
Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy. Int J Biochem Cell Biol (2008) 1.04
Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines. Cell Signal (2006) 1.04
Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate. Nucl Med Biol (2004) 1.02
Phosphatidylcholine-specific phospholipase C in mitogen-stimulated fibroblasts. Exp Cell Res (2004) 1.01
Protein kinase C and prostate carcinogenesis: targeting the cell cycle and apoptotic mechanisms. Curr Drug Targets (2004) 1.01
Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies. Anticancer Res (1996) 0.98
In vitro models to study cellular differentiation and function in human prostate cancers. Radiat Res (2001) 0.97
Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow. Blood (2000) 0.96
Cellular localization and functional role of phosphatidylcholine-specific phospholipase C in NK cells. J Immunol (2001) 0.96
Expression and regulation of phospholipase D isoforms in mammalian cell lines. J Cell Physiol (2000) 0.95
Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells. Eur J Immunol (2007) 0.95
Effects of phorbol ester on phospholipid metabolism. Prog Lipid Res (1990) 0.95
Regulation of phospholipase D2 activity by protein kinase C alpha. J Biol Chem (2004) 0.94
Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling. Oncogene (2002) 0.94
Phorbol ester-stimulated hydrolysis of phosphatidylcholine and phosphatidylethanolamine by phospholipase D in HeLa cells. Evidence that the basal turnover of phosphoglycerides does not involve phospholipase D. J Biol Chem (1991) 0.93
Protein kinase C-{alpha} mediates epidermal growth factor receptor transactivation in human prostate cancer cells. Mol Cancer Ther (2005) 0.92
Choline transporter as a novel target for molecular imaging of cancer. Mol Imaging (2006) 0.91
MARCKS is a downstream effector in platelet-derived growth factor-induced cell motility in activated human hepatic stellate cells. Exp Cell Res (2008) 0.90
Choline transporters in human lung adenocarcinoma: expression and functional implications. Acta Biochim Biophys Sin (Shanghai) (2007) 0.90
Phosphorylation of the yeast choline kinase by protein kinase C. Identification of Ser25 and Ser30 as major sites of phosphorylation. J Biol Chem (2005) 0.90
Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis. Biochim Biophys Acta (1995) 0.89
Role of the Akt pathway in prostate cancer. Curr Cancer Drug Targets (2009) 0.89
Changes in choline metabolism as potential biomarkers of phospholipase C{gamma}1 inhibition in human prostate cancer cells. Mol Cancer Ther (2009) 0.88
1-Butanol interferes with phospholipase D1 and protein kinase Calpha association and inhibits phospholipase D1 basal activity. Biochem Biophys Res Commun (2005) 0.88
Phospholipase D1 is located and activated by protein kinase C alpha in the plasma membrane in 3Y1 fibroblast cell. Biochim Biophys Acta (1999) 0.87
Phorbol ester selectively stimulates the phospholipase D-mediated hydrolysis of phosphatidylethanolamine in multidrug-resistant MCF-7 human breast carcinoma cells. Biochem J (1994) 0.87
Transforming growth factor-beta1 inhibits membrane association of protein kinase C alpha in a human prostate cancer cell line, PC3. Endocrinology (1997) 0.85
Lysophosphatidic acid induces process retraction in CG-4 line oligodendrocytes and oligodendrocyte precursor cells but not in differentiated oligodendrocytes. J Neurochem (2003) 0.84
Protein kinase C-alpha: a novel target for the therapy of androgen-independent prostate cancer? (Review-hypothesis). Oncol Rep (1998) 0.84
Phosphocholine and sphingosine-1-phosphate synergistically stimulate DNA synthesis by a MAP kinase-dependent mechanism. FEBS Lett (1997) 0.82
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment. Eur J Nucl Med Mol Imaging (2009) 0.80
Protein kinase C-alpha in prostate cancer. BJU Int (2004) 0.80
Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors. Cell Growth Differ (1994) 0.80
Synergistic potentiating effects of choline phosphate and ethanolamine on insulin-induced DNA synthesis in NIH 3T3 fibroblasts. Biochem Biophys Res Commun (1995) 0.80
D609, an inhibitor of phosphatidylcholine-specific phospholipase C, inhibits group IV cytosolic phospholipase A2. Mol Cells (2008) 0.79
c-fos promoter insensitivity to phorbol ester and possible role of protein kinase C in androgen-independent cancer cells. Cancer Res (1994) 0.79
Vasopressin and phorbol ester-stimulated phosphatidylcholine metabolism in mesangial cells. Am J Physiol (1992) 0.76
Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol (1998) 9.89
A map of local adaptation in Arabidopsis thaliana. Science (2011) 3.27
OCT elastography: imaging microscopic deformation and strain of tissue. Opt Express (1998) 3.05
Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation (2003) 2.97
Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product. Nature (1989) 2.78
Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME). Br J Dermatol (2014) 2.76
Sleep apnoea in heart failure. Eur Respir J (2007) 2.56
The serum-inducible mouse gene Krox-24 encodes a sequence-specific transcriptional activator. Mol Cell Biol (1990) 2.04
High-intensity focused ultrasound for prostate cancer: a systematic review. Clin Oncol (R Coll Radiol) (2010) 2.02
Amino-terminal domain of NF1 binds to DNA as a dimer and activates adenovirus DNA replication. EMBO J (1990) 1.95
Evidence of adaptive divergence in plasticity: density- and site-dependent selection on shade-avoidance responses in Impatiens capensis. Evolution (2000) 1.92
Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers. Ann Intern Med (1986) 1.89
Climate change and the integrity of science. Science (2010) 1.80
Plasticity to light cues and resources in Arabidopsis thaliana: testing for adaptive value and costs. Evolution (2000) 1.78
Intensity-modulated radiotherapy in the treatment of lung cancer. Clin Oncol (R Coll Radiol) (2012) 1.74
Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res (1998) 1.74
Patterns of fractures in accidental and non-accidental injury in children: a comparative study. Br Med J (Clin Res Ed) (1986) 1.61
Glucocorticoid receptor binds cooperatively to adjacent recognition sites. EMBO J (1989) 1.61
The European TREatment of severe Atopic eczema in children Taskforce (TREAT) survey. Br J Dermatol (2013) 1.60
Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology (2000) 1.48
Carcinoma of the penis in a HIV positive patient. Genitourin Med (1995) 1.47
Fracture patterns in Nottingham children. J Pediatr Orthop (1987) 1.46
A human flora-associated rat model of the breast-fed infant gut. J Pediatr Gastroenterol Nutr (2003) 1.43
Micromotor endoscope catheter for in vivo, ultrahigh-resolution optical coherence tomography. Opt Lett (2004) 1.42
Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process. Br J Cancer (2005) 1.42
The association of pregnancy and the development of obesity - results of a systematic review and meta-analysis on the natural history of postpartum weight retention. Int J Obes (Lond) (2007) 1.39
Community care outcomes. Br J Clin Pract (1995) 1.39
[Peri-ungual capillaroscopy. Value in the diagnosis of systemic diseases]. Presse Med (1993) 1.39
Measles immunity in a population of healthcare workers. Infect Control Hosp Epidemiol (1994) 1.33
Detection of the large external transformation-sensitive protein on some epithelial cells. Exp Cell Res (1977) 1.31
Is occupational solar ultraviolet irradiation a relevant risk factor for basal cell carcinoma? A systematic review and meta-analysis of the epidemiological literature. Br J Dermatol (2011) 1.27
Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin. J Biol Chem (1998) 1.25
Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. Eur J Cancer (1997) 1.21
The effect of maternal photoperiod on seasonal dormancy in Arabidopsis thaliana (Brassicaceae). Am J Bot (2001) 1.20
Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. J Leukoc Biol (2002) 1.19
Diagnosis of transient ischemic attack by the nonneurologist. A validation study. Stroke (1996) 1.16
Adaptive divergence in plasticity in natural populations of Impatiens capensis and its consequences for performance in novel habitats. Evolution (2001) 1.16
Genetic and physiological bases for phenological responses to current and predicted climates. Philos Trans R Soc Lond B Biol Sci (2010) 1.13
Biodegradation of cis-1,4-polyisoprene rubbers by distinct actinomycetes: microbial strategies and detailed surface analysis. Appl Environ Microbiol (2000) 1.13
Functional expression of sv40 in normal human prostatic epithelial and fibroblastic cells - differentiation pattern of nontumorigenic cell-lines. Int J Oncol (1995) 1.12
In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates. Br J Cancer (2000) 1.11
Flowering time plasticity in Arabidopsis thaliana: a reanalysis of Westerman & Lawrence (1970). J Evol Biol (2004) 1.11
A continuous spectrophotometric assay for P450 BM-3, a fatty acid hydroxylating enzyme, and its mutant F87A. Anal Biochem (1999) 1.07
Recognition and imitation of pantomimed motor acts after unilateral parietal and premotor lesions: a perspective on apraxia. Neuropsychologia (2001) 1.05
Lateral thyrotomy for neurilemmoma of the larynx. J Laryngol Otol (1999) 1.05
EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy (2011) 1.05
Optimization of helical tomotherapy treatment plans for prostate cancer. Phys Med Biol (2003) 1.04
Normal human tissues contain RNA and antigens related to infectious adenovirus type 2. Nature (1979) 1.04
Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study. Cancer (1994) 1.04
Human herpes simplex-1 and papillomavirus type 16 homologous DNA sequences in normal, potentially malignant and malignant oral mucosa. Eur J Cancer B Oral Oncol (1993) 1.04
[Ex situ sleeve resection and autotransplantation of the left lower pulmonary lobe after extended pneumonectomy]. Chirurg (2000) 1.03
Phase I and pharmacokinetic study of the oral fluoropyrimidine capecitabine in combination with paclitaxel in patients with advanced solid malignancies. J Clin Oncol (1999) 1.02
Radiotherapy for steroid-resistant laryngeal Rosai-Dorfman disease. Curr Oncol (2011) 1.01
Adsorption and desorption of natural organic matter on iron oxide: mechanisms and models. Environ Sci Technol (1994) 1.01
Density dependence and population differentiation of genetic architecture in Impatiens capensis in natural environments. Evolution (2000) 1.00
Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies. Clin Cancer Res (1998) 1.00
European multidisciplinary consensus statement on the use and monitoring of metal-on-metal bearings for total hip replacement and hip resurfacing. Orthop Traumatol Surg Res (2013) 0.99
Screening for medium chain acyl-CoA dehydrogenase deficiency has still not been evaluated. . BMJ (2001) 0.98
In vitro models to study cellular differentiation and function in human prostate cancers. Radiat Res (2001) 0.97
Assembly and DNA binding of recombinant Ku (p70/p80) autoantigen defined by a novel monoclonal antibody specific for p70/p80 heterodimers. J Cell Sci (1994) 0.96
Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer. Prostate Cancer Prostatic Dis (2007) 0.96
Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency. J Inherit Metab Dis (2005) 0.95
Diagnosis of stroke by the nonneurologist. A validation study. Stroke (1998) 0.94
Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis--a multinational cross-sectional study. Arch Dermatol Res (2013) 0.94
SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs. Int J Pharm (2004) 0.93
Determinants of eczema: population-based cross-sectional study in Germany. Allergy (2010) 0.93
[On the significance of aspects of recurring and granulomatous phlebitis in the cerebral manifestations of Behcet's disease]. Rev Neurol (Paris) (1966) 0.93
Incorporation of osteoblasts (MG63) into 3D nanofibre matrices by simultaneous electrospinning and spraying in bone tissue engineering. Eur Cell Mater (2011) 0.93
Retroperitoneal schwannoma presenting as an adrenal tumor. Exp Clin Endocrinol Diabetes (2000) 0.92
High-yield expression of the recombinant, atrazine-specific Fab fragment K411B by the methylotrophic yeast Pichia pastoris. J Immunol Methods (2001) 0.92
Comparison of geometry-based and CT voxel-based finite element modelling and experimental validation. Med Eng Phys (1998) 0.92
A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis. J Rheumatol (1991) 0.92
DNA isolation from soil samples for cloning in different hosts. Appl Microbiol Biotechnol (2004) 0.92
Multiple screening of medicinal plants from Oaxaca, Mexico: ethnobotany and bioassays as a basis for phytochemical investigation. Phytomedicine (1998) 0.91
Detection of serum antibodies to adult T-cell leukemia virus in non-human primates and in people from Africa. Int J Cancer (1983) 0.91
Occupational skin cancer induced by ultraviolet radiation and its prevention. Br J Dermatol (2012) 0.91
Frequency analysis of class I MHC-reactive Lyt-2+ and class II MHC-reactive L3T4+ IL 2-secreting T lymphocytes. J Immunol (1987) 0.90
Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment. J Eur Acad Dermatol Venereol (2012) 0.90
The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease. J Inherit Metab Dis (1999) 0.90
A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol (2013) 0.89
CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia. J Immunother (2001) 0.89
Rational evolution of a medium chain-specific cytochrome P-450 BM-3 variant. Biochim Biophys Acta (2001) 0.89
Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis. Immunobiology (1998) 0.89
Coordinate changes of polyamine metabolism regulatory proteins during the cell cycle of normal human dermal fibroblasts. FEBS Lett (1999) 0.89
Transspecific variability of soluble glutamic-pyruvic transaminase in primates. Humangenetik (1975) 0.89
Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology (2012) 0.89
Definite, probable or dubious: antioxidants trilogy in clinical dentistry. Br Dent J (2008) 0.88
Nonallergic comorbidities of atopic eczema: an overview of systematic reviews. Allergy (2013) 0.88
Xanthogranulomatous cholecystitis: a clinicopathological study from a tertiary care health institution. Kathmandu Univ Med J (KUMJ) (2009) 0.88
Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context. Cancer Gene Ther (2006) 0.88
Crosslinking of progesterone receptor to DNA using tuneable nanosecond, picosecond and femtosecond UV laser pulses. Nucleic Acids Res (1997) 0.87
Human androgen receptor expressed in HeLa cells activates transcription in vitro. Nucleic Acids Res (1994) 0.87
A rare cause of scrotal swelling: transitional cell carcinoma of the bladder presenting as a testicular metastasis. Adv Urol (2011) 0.86
Characterization of Bordetella pertussis growing as biofilm by chemical analysis and FT-IR spectroscopy. Appl Microbiol Biotechnol (2005) 0.86
Risk of occupational exposure to potentially infectious nonhuman primate materials and to simian immunodeficiency virus. J Med Primatol (1997) 0.86
[Minimally invasive balloon-assisted reduction and internal fixation of tibial plateau fractures]. Unfallchirurg (2012) 0.86
Susceptibility to UV damage in Impatiens capensis (Balsaminaceae): testing for opportunity costs to shade-avoidance and population differentiation. Am J Bot (2001) 0.86
Characterization of food spoilage fungi by FTIR spectroscopy. J Appl Microbiol (2013) 0.86
Heme modulates smooth muscle cell proliferation and migration via NADPH oxidase: a counter-regulatory role for heme oxygenase system. Atherosclerosis (2012) 0.85